Aptar Reports Fourth Quarter and Annual 2023 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter operational results driven by double-digit growth of the company’s proprietary drug delivery systems and strong growth fo...

Related Keywords

Russia ,Illinois ,United States ,Ukraine ,Crystal Lake ,America ,American ,Russian ,Aptar Pharma ,Mary Skafidas ,Exchange Commission ,Research Development ,Net Income Attributable To Aptargroup Inc ,Aptargroup Inc ,Securities Exchange ,Aptargroup ,Aptar President ,Change Over Prior Year ,North American ,Investor Relations ,Securities Act ,Securities Exchange Act ,Middle East ,Financial Condition ,Consolidated Financial Statements ,Except Per Share Data ,Income Attributable ,Common Share ,Shares Outstanding ,Notes Receivable ,Net Income ,Reported Net Sales ,Relations Contact ,